Results 191 to 200 of about 51,205 (307)

Safety of bioelectrical impedance analysis in patients with cardiac implantable electronic devices: A systematic review. [PDF]

open access: yesHeart Rhythm O2
Uribe-Cavero LJ   +7 more
europepmc   +1 more source

Psychosocial Factors Mediate the Relationship Between Olfactory Function and Cognitive Frailty in Older Adults: A Structural Equation Modelling

open access: yesAustralasian Journal on Ageing, Volume 45, Issue 2, June 2026.
ABSTRACT Objective With the trend of population ageing, cognitive frailty in older adults is an increasingly pressing public health issue. Identifying early‐stage risk factors has become a key priority for researchers with the goal of preventing disability.
Li‐Jun Chen   +6 more
wiley   +1 more source

Aerobic Exercise Plus Hypocaloric Diet on Serum Leptin Concentrations in Adults With Primary Hypertension and Overweight/Obesity: Results From the EXERDIET‐HTA Trial

open access: yesClinical Obesity, Volume 16, Issue 3, June 2026.
Aerobic exercise plus hypocaloric diet on serum leptin concentrations in adults with primary hypertension and Overweight/Obesity. ABSTRACT Hyperleptinaemia is an emerging mechanism involved in the pathogenesis of obesity‐related primary hypertension (HTN).
Virginia A. Aparicio   +4 more
wiley   +1 more source

Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo‐Controlled, Double‐Blind, Crossover Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4671-4682, June 2026.
ABSTRACT Introduction Oxytocin is expressed throughout the small intestine, suggesting a role for oxytocin in postprandial metabolism. Accordingly, single‐dose intranasal oxytocin reduces food intake and improves glucose tolerance. We investigated the effects of a continuous intravenous oxytocin infusion on ad libitum food intake, appetite sensations ...
Ida M. Gether   +13 more
wiley   +1 more source

Contemporary concepts in ‘exercise as medicine’ and related fields

open access: yes
Experimental Physiology, EarlyView.
Daniel H. Craighead   +11 more
wiley   +1 more source

SEMASEARCH Study Design: Real‐World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4602-4609, June 2026.
ABSTRACT Background Although semaglutide 2.4 mg has demonstrated significant weight loss efficacy in clinical trials, real‐world data, particularly with regard to clinically complex and underrepresented populations, remain limited. Objectives The study aims to assess the real‐world effectiveness and patient‐reported outcomes associated with the use of ...
Pierre Bel Lassen   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy